Stratec SE (XTER:SBS) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


XTER:SBS Stratec SE XTER:SBS
64 GF Score
Price €17.68
GF Value €32.21
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Stratec SE Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Stratec SE's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

XTER:SBS vs ABT, SYK, MDT: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Stratec SE's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stratec SE Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Stratec SE's Margin of Safety % (DCF Earnings Based) falls into.


XTER:SBS
64GF Score
Stratec SE XTER:SBS
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Stratec SE (XTER:SBS) Overvalued in 2026?

Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued. The current stock price of €17.68 is trading 45.1% below its estimated GF Value™ of €32.21. GuruFocus considers Stratec SE to be Significantly Undervalued.

Key valuation signals for XTER:SBS:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €32.21 vs. price of €17.68 (45.1% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the XTER:SBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stratec SE Business Description

Other Exchanges 0RAR:UKSBSG:Austria
Address Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
64GF Score

Get the complete analysis for XTER:SBS

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.68
Price
€32.21
GF Value